New software tool for analyzing kinases; Dotmatics software to support Cancer Therapeutics CRC;

> R&D software provider Dotmatics says that Cancer Therapeutics CRC has deployed the company's enterprise platform for research at multiple locations. Item

> Formedix has spotlighted the company's latest Transform for Publication products for clinical trials data. Release

> A group from the University of Saskatchewan has developed software to analyze kinases, which, when mutated, are culprits in a number of cancers. Announcement

> An informatics expert from the Ohio State University plans to upgrade a web-based tool for analyzing large datasets to help researchers explore the spread of infectious diseases. Report

> Biovest International ($BVTI) has tapped Dr. Eduardo Sotomayor of the H. Lee Moffitt Cancer Center & Research Institute in Tampa for its scientific advisory board. Release

 

 

Suggested Articles

APAC organizations are nearly five times slower than the global average to detect cyber intrusions (Image imaginima / iStockPhoto)
Biotech

Email hacker gains access to Sangamo's proprietary info

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

by Conor Hale
A doctor sitting at his desk working on a laptop computer.
CRO

AllTrials launches clinical trial results reporting tracker

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

by Angus Liu
DNA computer
CRO

DNAnexus launches NGS-based clinical trial solution

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

by Angus Liu